Cognitive-Behavioral Therapy for ADHD in College Students (ADHD Trial)

N/A

Recruiting

Led By Mary V. Solanto, Ph.D.

Research Sponsored by Northwell Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline brief-a at 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will help college students with ADHD develop skills to succeed in their studies and avoid negative academic outcomes.

Who is the study for?

This trial is for college students at The City College of New York who have been diagnosed with ADHD, either Inattentive or Combined Subtype. Participants should be in good physical health. It's not open to individuals who are actively suicidal, have certain psychiatric disorders like bipolar disorder or borderline personality disorder, a history of severe childhood trauma, neurological issues, recent drug or alcohol abuse, or any acute psychiatric condition that requires immediate treatment.

What is being tested?

The study is testing a cognitive-behavioral therapy program designed to help college students with ADHD improve their self-management skills. This includes better time management and planning to enhance academic performance and reduce the likelihood of negative educational outcomes.

What are the potential side effects?

Since this trial involves psychological therapy rather than medication, traditional side effects associated with drugs are not expected. However, participants may experience emotional discomfort discussing personal issues during therapy sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline aisrs at six months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline aisrs at six months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline aisrs at six months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change from Baseline Adult Investigator Symptom Rating Scale (AISRS) at six months

Change from Baseline Behavior Rating Scale of Executive Function - Adult Version (BRIEF-A) at six months

Change from Baseline Learning and Study Strategies Inventory (LASSI) at six months

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Cognitive Behavioral Therapy delivered in a group formatExperimental Treatment1 Intervention

Participating students will be assessed before and after the 12-week group Cognitive-Behavioral intervention to ascertain their response to the treatment.

Do I qualify?Apply below to find out